CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 94 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,133,486 | +40.1% | 194,090 | +60.8% | 0.00% | 0.0% |
| Q3 2022 | $809,000 | +16080.0% | 120,717 | +7132.9% | 0.00% | – |
| Q3 2021 | $5,000 | -37.5% | 1,669 | -14.4% | 0.00% | – |
| Q2 2021 | $8,000 | -38.5% | 1,950 | -24.2% | 0.00% | – |
| Q1 2021 | $13,000 | -84.3% | 2,572 | -60.7% | 0.00% | – |
| Q4 2020 | $83,000 | +538.5% | 6,539 | +375.9% | 0.00% | – |
| Q3 2020 | $13,000 | -97.2% | 1,374 | -97.0% | 0.00% | – |
| Q2 2020 | $461,000 | +523.0% | 46,310 | +449.7% | 0.00% | – |
| Q1 2020 | $74,000 | +57.4% | 8,424 | +64.1% | 0.00% | – |
| Q4 2019 | $47,000 | +161.1% | 5,135 | +64.8% | 0.00% | – |
| Q3 2019 | $18,000 | -80.2% | 3,115 | -58.8% | 0.00% | – |
| Q2 2019 | $91,000 | +7.1% | 7,554 | +6.5% | 0.00% | – |
| Q1 2019 | $85,000 | +26.9% | 7,091 | +32.5% | 0.00% | – |
| Q4 2018 | $67,000 | -13.0% | 5,352 | +2.6% | 0.00% | – |
| Q3 2018 | $77,000 | +18.5% | 5,216 | +34.4% | 0.00% | – |
| Q2 2018 | $65,000 | -25.3% | 3,880 | +2.6% | 0.00% | – |
| Q1 2018 | $87,000 | -25.6% | 3,781 | -16.3% | 0.00% | – |
| Q4 2017 | $117,000 | +108.9% | 4,519 | +18.2% | 0.00% | – |
| Q3 2017 | $56,000 | +3.7% | 3,823 | -1.6% | 0.00% | – |
| Q2 2017 | $54,000 | +260.0% | 3,887 | +334.8% | 0.00% | – |
| Q1 2017 | $15,000 | +66.7% | 894 | +6.6% | 0.00% | – |
| Q4 2016 | $9,000 | +12.5% | 839 | 0.0% | 0.00% | – |
| Q3 2016 | $8,000 | -89.7% | 839 | -87.9% | 0.00% | – |
| Q2 2016 | $78,000 | -63.2% | 6,928 | -55.4% | 0.00% | – |
| Q1 2016 | $212,000 | +26.9% | 15,535 | +76.1% | 0.00% | – |
| Q4 2015 | $167,000 | +328.2% | 8,822 | +321.3% | 0.00% | – |
| Q3 2015 | $39,000 | -9.3% | 2,094 | -27.7% | 0.00% | – |
| Q2 2015 | $43,000 | +19.4% | 2,895 | +21.7% | 0.00% | – |
| Q1 2015 | $36,000 | -32.1% | 2,379 | -39.9% | 0.00% | – |
| Q4 2014 | $53,000 | +5200.0% | 3,958 | +7660.8% | 0.00% | – |
| Q3 2014 | $1,000 | -99.8% | 51 | -99.9% | 0.00% | -100.0% |
| Q2 2014 | $582,000 | +1718.8% | 57,617 | +2296.7% | 0.00% | – |
| Q1 2014 | $32,000 | – | 2,404 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 4,420,349 | $25,814,838 | 3.96% |
| Parkman Healthcare Partners LLC | 1,203,484 | $7,028,347 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,002,783 | $5,856,253 | 1.26% |
| TANG CAPITAL MANAGEMENT LLC | 1,150,000 | $6,716,000 | 0.98% |
| BVF INC/IL | 3,629,000 | $21,193,360 | 0.89% |
| Nantahala Capital Management | 1,732,388 | $10,117,146 | 0.66% |
| AWM Investment Company, Inc. | 666,661 | $3,893,300 | 0.56% |
| INGALLS & SNYDER LLC | 1,295,833 | $7,568 | 0.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 200,800 | $1,172,672 | 0.36% |
| Kensington Investment Counsel, LLC | 58,599 | $342,218 | 0.27% |